Repare Therapeutics Inc. (RPTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 11.62M | 250K | 0 | 0 | 0 | 1.07M | 52.4M | 13.05M | 2.16M | 30.25M | 5.68M | 18.2M |
| Revenue Growth % | - | -76.7% | -100% | -100% | -100% | -96.45% | 822.93% | -28.31% | -98.08% | 4354.93% | 1291.67% | 164.62% |
| Cost of Goods Sold | 0 | 0 | 1.19M | 454K | 478K | 488K | 501K | 506K | 1.05M | 1.05M | 982K | 27.55M |
| COGS % of Revenue | - | - | - | - | - | 45.48% | 0.96% | 3.88% | 48.59% | 3.47% | 17.29% | 151.37% |
| Gross Profit | 11.62M | 250K | -1.19M | -454K | -478K | 585K | 51.9M | 12.54M | 1.11M | 29.2M | 4.7M | -9.35M |
| Gross Margin % | 100% | 100% | - | - | - | 54.52% | 99.04% | 96.12% | 51.41% | 96.53% | 82.71% | -51.37% |
| Gross Profit Growth % | 2530.96% | -57.27% | -102.28% | -103.62% | -143.06% | -98% | 1005.26% | 234.14% | -99% | 7567.52% | 118.03% | 50.54% |
| Operating Expenses | 10.49M | 18.03M | 26.6M | 30.2M | 34.13M | 37.64M | 41.09M | 42.99M | 39.22M | 41.09M | 39M | 10.28M |
| OpEx % of Revenue | 90.27% | 7212% | - | - | - | 3508.29% | 78.4% | 329.52% | 1816.72% | 135.85% | 686.83% | 56.51% |
| Selling, General & Admin | 4.55M | 6.03M | 7.65M | 5.85M | 6.44M | 8.32M | 8.62M | 8.53M | 7.32M | 8.17M | 7.99M | 10.28M |
| SG&A % of Revenue | 39.14% | 2411.6% | - | - | - | 775.12% | 16.45% | 65.39% | 338.91% | 27.02% | 140.68% | 56.51% |
| Research & Development | 7.5M | 14.28M | 18.95M | 24.36M | 27.68M | 29.33M | 32.47M | 34.46M | 31.91M | 32.92M | 31.01M | 30.29M |
| R&D % of Revenue | 64.56% | 5713.2% | - | - | - | 2733.18% | 61.96% | 264.12% | 1477.81% | 108.82% | 546.14% | 166.45% |
| Other Operating Expenses | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K |
| Operating Income | 1.13M | -17.78M | -27.79M | -30.66M | -34.61M | -37.06M | 10.82M | -30.45M | -38.11M | -11.89M | -34.3M | -19.63M |
| Operating Margin % | 9.73% | -7112% | - | - | - | -3453.77% | 20.64% | -233.39% | -1765.31% | -39.32% | -604.12% | -107.88% |
| Operating Income Growth % | 103.27% | 52.02% | -356.91% | -0.67% | 9.2% | -211.58% | 131.53% | -55.11% | -151.71% | 69.03% | 1.51% | 31.68% |
| EBITDA | 1.2M | -16.74M | -26.6M | -30.2M | -34.13M | -36.57M | 11.32M | -29.95M | -37.06M | -10.84M | -33.32M | -19.18M |
| EBITDA Margin % | 10.35% | -6697.6% | - | - | - | -3408.29% | 21.6% | -229.52% | -1716.72% | -35.85% | -586.83% | -105.38% |
| EBITDA Growth % | 103.52% | 54.22% | -335.05% | -0.86% | 7.92% | -237.28% | 133.96% | -56.15% | -149.59% | 70.96% | 2.89% | 32.39% |
| D&A (Non-Cash Add-back) | 72K | 1.04M | 1.19M | 454K | 478K | 488K | 501K | 506K | 1.05M | 1.05M | 982K | 455K |
| EBIT | 3.4M | -20.06M | -29.54M | -28.53M | -33.68M | -34.19M | 10.82M | -27.42M | -34.87M | -8.47M | -30.95M | -19.63M |
| Net Interest Income | 2.22M | 1.24M | 1.54M | 2.02M | 2.51M | 2.89M | 2.97M | 3.11M | 3.31M | 3.49M | 3.43M | 2.93M |
| Interest Income | 2.22M | 1.24M | 1.54M | 2.02M | 2.51M | 2.89M | 2.97M | 3.11M | 3.31M | 3.49M | 3.43M | 2.93M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.27M | 1.28M | -1.75M | 2.13M | 924K | 2.87M | 2.98M | 3.03M | 3.24M | 3.42M | 3.36M | 3M |
| Pretax Income | 3.4M | -16.5M | -29.54M | -28.53M | -33.68M | -34.19M | 13.79M | -27.42M | -34.87M | -8.47M | -30.95M | -16.63M |
| Pretax Margin % | 29.29% | -6598.4% | - | - | - | -3186.21% | 26.32% | -210.19% | -1615.24% | -28.01% | -545.02% | -91.38% |
| Income Tax | 145K | 248K | 505K | 140K | 723K | 586K | 629K | 606K | -15.99M | 3.47M | 4M | 15.03M |
| Effective Tax Rate % | 4.26% | -1.5% | -1.71% | -0.49% | -2.15% | -1.71% | 4.56% | -2.21% | 45.86% | -41.01% | -12.91% | -90.37% |
| Net Income | 3.26M | -16.74M | -30.04M | -28.67M | -34.41M | -34.77M | 13.16M | -28.03M | -18.88M | -11.95M | -34.94M | -31.66M |
| Net Margin % | 28.04% | -6697.6% | - | - | - | -3240.82% | 25.12% | -214.84% | -874.43% | -39.49% | -615.38% | -173.96% |
| Net Income Growth % | 109.47% | 51.85% | -328.26% | -2.29% | -82.24% | -191.09% | 137.67% | 11.46% | -125.02% | 68.64% | -0.53% | -11.91% |
| Net Income (Continuing) | 3.26M | -16.74M | -30.04M | -28.67M | -34.41M | -34.77M | 13.16M | -28.03M | -18.88M | -11.95M | -34.94M | -31.66M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.08 | -0.39 | -0.71 | -0.67 | -0.81 | -0.82 | 0.30 | -0.67 | -0.45 | -0.28 | -0.83 | -0.75 |
| EPS Growth % | 109.88% | 52.44% | -336.67% | 0% | -80% | -192.86% | 136.14% | 10.67% | -126.32% | 69.23% | 0% | -7.14% |
| EPS (Basic) | 0.08 | -0.39 | -0.71 | -0.67 | -0.81 | -0.82 | 0.31 | -0.67 | -0.45 | -0.28 | -0.83 | -0.75 |
| Diluted Shares Outstanding | 43.05M | 42.92M | 42.59M | 42.41M | 42.45M | 42.45M | 44.02M | 42.14M | 42.1M | 42.09M | 42.04M | 42.04M |
| Basic Shares Outstanding | 42.97M | 42.92M | 42.59M | 42.41M | 42.45M | 42.45M | 42.23M | 42.14M | 42.1M | 42.09M | 42.04M | 42.04M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |